Mary P E Ng Selected Research

2- (4- (quinolin- 2- yl- methoxy)phenyl)- 2- cyclopentylacetic acid

1/2020

Early and Sustained Increases in Leukotriene B4 Levels Are Associated with Poor Clinical Outcome in Ischemic Stroke Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary P E Ng Research Topics

Disease

1	Stroke (Strokes) 01/2020
1	Embolic Stroke 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020
1	Brain Infarction 01/2020
1	Infarction (Infarctions) 01/2020
1	Ischemic Stroke 01/2020
1	Myalgia 09/2014
1	Fatigue 09/2014
1	Infections 09/2014
1	Human Influenza (Influenza) 09/2014
1	Arthralgia (Joint Pain) 09/2014
1	Parkinson Disease (Parkinson's Disease) 07/2014

Drug/Important Bio-Agent (IBA)

1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Leukotriene Receptors (Leukotriene Receptor)IBA 01/2020
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	LY 255283IBA 01/2020
1	2- (4- (quinolin- 2- yl- methoxy)phenyl)- 2- cyclopentylacetic acidIBA 01/2020
1	Leukotriene B4IBA 01/2020
1	C-Reactive ProteinIBA 09/2014
1	Biomarkers (Surrogate Marker)IBA 09/2014
1	F2-Isoprostanes (F2 Isoprostanes)IBA 09/2014
1	coenzyme Q10 (CoQ10)IBA 07/2014